supported by grants from the Chinese National Key Technology R&D Program,Ministry of Science and Technology(Nos.2021YFC2501301-5,2017YFC0907601-3);Beijing Municipal Science&Technology Commission(No.Z201100005520022,23,25-27);CAMS Innovation Fund for Medical Sciences(CIFMS)(No.2021-I2M-1-005).
To the Editor:Systemic lupus erythematosus(SLE)is an autoimmune disease involving multiple systems.In recent years,the therapeutic treat-to-target(T2T)strategy was recommended for SLE.^([1])The immunosuppressive drugs...